Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Infections following medical leech therapy for rhizarthrosis: a case series.

Created on 18 Oct 2026

Authors

Laura Coenen de Salazar, Stefan Weber, Martin Lautenbach

Published in

Case reports in plastic surgery & hand surgery. Volume 13. Issue 1. Pages 2741520. Epub Oct 15, 2026.

Abstract

Medical leech therapy is used as an alternative treatment for chronic pain conditions, including rhizarthrosis. During leech therapy, the leech releases a variety of bioactive substances that are intended to alleviate symptoms and relieve pain. The procedure is often described as a 'natural' and risk-free form of naturopathic treatment. However, medical leech therapy is associated with risks and potential complications, among which infection is one of the most common. According to the literature, these infections may be caused by Aeromonas spp. as well as other pathogens. Treatment typically consists of intravenous antibiotic therapy combined with surgical intervention. We report a case series of five patients who presented to the Department of Hand Surgery at Waldfriede Hospital with infections following medical leech therapy for rhizarthrosis. No consistent microbiological pattern of causative pathogens was observed. Several strategies for preventing infections associated with medical leech therapy have been described in the literature. Nevertheless, serious infectious complications cannot be entirely excluded.

PMID:
42891380
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement